Qudexy Capsule, Extended Release
Pricing Report NDC 0245-1071-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Qudexy Xr (NDC 0245-1071-30) is $9.32500 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 23, 2025.

As a a human prescription drug provided by Upsher-smith Laboratories, Llc, this medication is distributed in a 1 BOTTLE in 1 CARTON / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.32500
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 23, 2025
Billable Units
1 EA
Estimated Package Price
$9.32
Data Status
As of Dec 31, 2025
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
0245-1071-30
Description
1 BOTTLE in 1 CARTON / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $3.67347 (Effective: Dec 17, 2025)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2025, the NADAC wholesale price for (NDC ) has moved within a range of $9.32500 to $9.33733 per EA. Over this 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$9.3250 - $9.3373
Market Volatility
0.13% Variance
Latest Trend
0.10%
Date Unit Price Unit Source Method Rate
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Apr 23, 2025 $9.32500 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 19, 2025 $9.33417 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 19, 2025 $9.33733 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026